Similar Papers

Paper Title
Journal
Date
Author
Efficacy and Safety of Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in Subjects Aged 1-3 Years With and Without Atopic Dermatitis in the EPITOPE Study
Amy Scurlock ... A Wesley Burks
Journal of Allergy and Clinical Immunology | VOL. 151
Amy Scurlock, et. al.Amy Scurlock ... A Wesley Burks
01 Feb 2023
From Skin to Solution: Exploring Epicutaneous Immunotherapy for Peanut Allergy-A Systematic Review and Meta-Analysis.
Umm E Salma Shabbar Banatwala ... Ali Ajam
Clinical reviews in allergy & immunology | VOL. 66
Umm E Salma Shabbar Banatwala, et. al.Umm E Salma Shabbar Banatwala ... Ali Ajam
25 Mar 2024
Epithelial immunotherapy for food allergy in children: a systematic review and meta-analysis
Bin Chen ... Fajuan Tang
Frontiers in Immunology | VOL. 15
Bin Chen, et. al.Bin Chen ... Fajuan Tang
23 Dec 2024
The Efficacy and Safety of Epicutaneous Immunotherapy for Allergic Diseases: A Systematic Review and Meta-Analysis
Limei Xiong ... Wencong Chen
International Archives of Allergy and Immunology | VOL. 181
Limei Xiong, et. al.Limei Xiong ... Wencong Chen
04 Dec 2019
View more papers

More From: Journal of Allergy and Clinical Immunology

Paper Title
Journal
Date
Author
News beyond our pages
-
Journal of Allergy and Clinical Immunology | VOL. 155
--
01 Jan 2025
Anaphylaxis definition, overview, and clinical support tool: 2024 consensus report
Timothy E Dribin ... Gary Wing-Kin Wong
Journal of Allergy and Clinical Immunology | VOL. -
Timothy E Dribin, et. al.Timothy E Dribin ... Gary Wing-Kin Wong
01 Jan 2025
Brief Overview of This Month's JACI
-
Journal of Allergy and Clinical Immunology | VOL. 155
--
01 Jan 2025
Is there a role for vitamin supplementation in pollutant-related childhood asthma?
Allen Joe ... Juan C Celedón
Journal of Allergy and Clinical Immunology | VOL. -
Allen Joe, et. al.Allen Joe ... Juan C Celedón
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.